doi:10.1007/s12250-015-3582-7

[1]
严亚琼, 陈冬峨, 曾艳彩, , , , 2004: Study on Risk Relationship between Hepatitis B Virus and Primary Hepatocellular Carcinoma, Virologica Sinica, 19, 549-552.
[2]
Xiaojing Kuang, Lingling Sun, Shuzhen Liu, Zhenzhen Zhao, Danrui Zhao, Song Liu, Bing Luo, 2016: Association of single nucleotide polymorphism rs2065955 of the filaggrin gene with susceptibility to Epstein-Barr virus-associated gastric carcinoma and EBV-negative gastric carcinoma, Virologica Sinica, 31, 306-313. doi: 10.1007/s12250-016-3721-9
[3]
陈冬峨, 严亚琼, 曾艳彩, , , , 2004: The Relationship between Hepatocellular Cacinoma and Hepatitis B Virus Infection, Virologica Sinica, 19, 520-522.
[4]
周经姣, 刘建军, 徐顺先, , , 2003: p53 Expression and Genetic Evidence for Virus Infection in Cervical Carcinoma, Virologica Sinica, 18, 197-200.
[5]
王文亮王春杰师建国王冰枫, , , , 2001: Distribution and Significance of HCV and HBV Genes and Their Related Antigens in Hepatocellular Carcinoma, Virologica Sinica, 16, 325-329.
[6]
方钟燎, 杨进业, 王学燕, 庄辉, Roger Ling, Tim J Harrison, 2000: The Discovery of HBV Core Tissue of Patients with Prom oter M Ⅱtations in Tum our Hepatocellular Carcinoma, Virologica Sinica, 15, 234-248.
[7]
雷森林, 郭淑芳, 董长垣, , , , 2006: Apoptosis of the Human Hepatic Carcinoma 3B Cells Induced by Bluetongue Virus HbC3 Strain, Virologica Sinica, 21, 556-559.
[8]
潘文胜, 王海涛, 汪涛, 郭华章, 骆抗先, 1998: Genetic variation characteristics of hepatitis C virus hypervariable region, Virologica Sinica, 13, 221-.
[9]
Ju-sheng LIN, Lin-lin GAO, 2008: Advances in Research on Hepatitis B Virus DNA Integration, Virologica Sinica, 23, 93-99. doi: 10.1007/s12250-008-2939-6
[10]
郭亚兵, 侯金林, 戴炜, 骆抗先, P.Karayiannis, 1999: Sequencing of the W hole Gene of Hepatitis B Virus, Virologica Sinica, 14, 205-209.
[11]
范涛, 傅希贤, 张国庆, 张乃临, 1994: The Inhibitory Effects of Quinolones on Hepatitis B Virus in Vitro, Virologica Sinica, 9, 113-118.
[12]
吴婷, 黄海, 1998: The Inhibitory Effects of Enduracidin on Hepatitis B Virus in vitro, Virologica Sinica, 13, 45-.
[13]
Jianhao Cao, Shuhong Luo, Yuanyan Xiong, 2019: The Variability of Amino Acid Sequences in Hepatitis B Virus, Virologica Sinica, 34, 42-49. doi: 10.1007/s12250-018-0070-x
[14]
熊开钧, 王心禾, 黄华芳, 姚梦林, 代家珠, 金慰鄂, 范红梅, 曾全兰, 张雪珍, 1987: THE OBSERVATION OF A TREATED RESULT WITH ACYCLOVIR IN HEPATITIS B VIRUS, Virologica Sinica, 2, 78-.
[15]
Yang XU, Chun-wei SHE, Xiao-yong ZHANG, Rong-juan PEI, Meng-ji LU, 2008: Interference of Hepatitis B Virus with Cellular Signaling^*, Virologica Sinica, 23, 100-106. doi: 10.1007/s12250-008-2940-0
[16]
Yin-ping LU, Bao-ju WANG, Ji-hua DONG, Zhao LIU, Shi-he GUAN, Meng-ji LU, Dong-liang YANG, 2007: Construction and Characterization of a Hepatitis B Virus Replicon, Virologica Sinica, 22, 8-13.
[17]
Felicia Tucci, Ralf Küppers, 2014: Role of hepatitis C virus in B cell lymphoproliferations, Virologica Sinica, 29, 3-6. doi: 10.1007/s12250-014-3414-1
[18]
Song Hu, Fahu Yuan, Lingyan Feng, Fang Zheng, Feili Gong, Hanju Huang, Binlian Sun, 2018: KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China, Virologica Sinica, 33, 369-372. doi: 10.1007/s12250-018-0042-1
[19]
高英堂, 陈瑞阳, 宋文芹, 陈成彬, 齐之丽, 景丽, 孙金英, 钱绍诚, 2003: DNA M icroarray for M onitoring Genetic Variability ofHepatitis B virus during Lamivudine Therapy, Virologica Sinica, 18, 523-529.
[20]
Chunchen Wu, Hui Shi, Yun YunWang, Mengji Lu, Yang Xu, Xinwen Chen, 2012: A Case of Hepatitis B Reactivation due to the Hepatitis B Virus Escape Mutant in a Patient undergoing Chemotherapy ^*, Virologica Sinica, 27, 369-372. doi: 10.1007/s12250-012-3284-3